Open access · CC-BY
via OpenAlex
Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells
Yunqian Guan, Chunsong Zhao, Haiqiang Zou, Xiao‑Ming Yan, Lu‐Lu Luo, Jia‑Lin Wu, Xiaobo Li, Yu Zhang
Molecular Medicine Reports · 2018 · ▲ 4 citations
Abstract
Whether aging or Parkinson's disease (PD) affects the responses of peripheral blood mononuclear cells (PBMCs) to immunosuppression by bone marrow‑derived mesenchymal stem cell (BM‑MSCs) and which cytokines are more effective in inducing BM‑MSCs to be immunosuppressive remains to be elucidated. PBMCs were isolated from healthy young (age 26‑35), healthy middle‑aged (age 56‑60) and middle‑aged PD‑affected individuals. All the recruits were male. The mitogen‑stimulated PBMCs and proinflammatory cytokine‑pretreated BM‑MSCs were co‑cultured. The PBMC proliferation was measured using Cell Counting Kit‑8, while the cytokine secretion was assayed by cytometric bead array technology. The immunosuppressive ability of BM‑MSCs was confirmed in young healthy, middle‑aged healthy and middle‑aged PD‑affected individuals. Among the three groups, the PBMC proliferation and cytokine secretion of the young healthy group were suppressed more significantly compared with those of the middle‑aged healthy and middle‑aged PD‑affected group. No significant differences were identified in the PBMC proliferation and cytokine secretion between the patients with PD and the middle‑aged healthy subjects. Interferon (IFN)‑γ synergized with tumor necrosis factor (TNF)‑α, interleukin (IL)‑1α or IL‑1β was more effective than either one alone, and the combinations of IFN‑γ + IL‑1α and IFN‑γ + IL‑1β were more effective than IFN‑γ + TNF‑α in inducing BM‑MSCs to inhibit PBMC proliferation. The results of the present study suggested that aging, rather than PD, affects the response of PBMCs toward the suppression of BM‑MSC, at least in middle‑aged males. Patients with PD aged 56‑60 remain eligible for anti‑inflammatory BM‑MSC‑based therapy. Treatment of BM‑MSCs with IFN‑γ + IL‑1α or IFN‑γ + IL‑1β prior to transplantation may result in improved immunosuppressive effects.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.3892/mmr.2018.9670
- Canonical
- link ↗
- Fetched
- 2026-11-01 MST
Cite this
APA
Guan, Y., Zhao, C., Zou, H., Yan, X., Luo, L., Wu, J., Li, X., & Zhang, Y. (2018). Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells. <em>Molecular Medicine Reports</em>. https://doi.org/10.3892/mmr.2018.9670
Vancouver
Guan Y, Zhao C, Zou H, Yan X, Luo L, Wu J, et al. Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells. Molecular Medicine Reports. 2018. doi:10.3892/mmr.2018.9670.
BibTeX
@article{yunqian2018Agingr,
title = {Aging, rather than Parkinson's disease, affects the responsiveness of PBMCs to the immunosuppression of bone marrow mesenchymal stem cells},
author = {Yunqian Guan and Chunsong Zhao and Haiqiang Zou and Xiao‑Ming Yan and Lu‐Lu Luo and Jia‑Lin Wu and Xiaobo Li and Yu Zhang},
journal = {Molecular Medicine Reports},
year = {2018},
doi = {10.3892/mmr.2018.9670},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Frontiers in Bioengineering and Biotechnology 2022
Open access · CC-BY
Inflammatory Microenvironment Accelerates Bone Marrow Mesenchymal Stem Cell Aging
2001
Citation only
Study on the relationship between bone metabolism indexes and osteoporosis in aged males
Scientific Reports 2021
Open access · CC-BY
Photobiomodulation has rejuvenating effects on aged bone marrow mesenchymal stem cells
Cell Biology International 2012
Citation only
Bone marrow derived mesenchymal stem cells from aged mice have reduced wound healing, angiogenesis, proliferation and anti‐apoptosis capabilities
International Journal of Medical Sciences 2018
Open access · CC-BY
The replicative senescent mesenchymal stem / stromal cells defect in DNA damage response and anti-oxidative capacity
Stem Cell Research & Therapy 2018
Open access · CC-BY